Have a personal or library account? Click to login
From data to hypothesis: Exploring monocyte immunometabolism by principal component analysis of multiparametric flow cytometry Cover

From data to hypothesis: Exploring monocyte immunometabolism by principal component analysis of multiparametric flow cytometry

Acta Marisiensis - Seria Medica
Volume 71 (2025): Issue 3 (September 2025)
By: Ion Bogdan Mănescu,  Daniel Gîrlea,  Sara Thomas,  Ana Maria Fotache and  Liliana Demian  
Open Access
|Sep 2025

Authors

Ion Bogdan Mănescu

Department of Laboratory Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania

Daniel Gîrlea

Medical Campus Hamburg, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Germany

Sara Thomas

George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania

Ana Maria Fotache

fotache.anamaria@yahoo.com

Clinical Laboratory, Emergency County Clinical Hospital of Targu Mures, Romania

Liliana Demian

Center for Advanced Medical and Pharmaceutical Research (CCAMF), Targu Mures, Romania
DOI: https://doi.org/10.2478/amma-2025-0033 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 211 - 216
Submitted on: Jul 3, 2025
|
Accepted on: Jul 9, 2025
|
Published on: Sep 18, 2025
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
body mass index,
LDLR,
monocyte,
multiparametric flow cytometry,
principal component analysis
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2025 Ion Bogdan Mănescu, Daniel Gîrlea, Sara Thomas, Ana Maria Fotache, Liliana Demian, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 71 (2025): Issue 3 (September 2025)Next article